Impact of recipient CMV status on outcome after T-depleted volunteer unrelated donor (VUD) transplantation for CML.

被引：0
|
作者：
Craddock, C
Szydlo, R
Ward, K
Yong, A
Brookes, P
Kanfer, E
Apperley, J
Goldman, J
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Virol, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Immunol, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
187
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Impact of recipient CMV status on outcome after T-depleted VUD transplantation for CML.
    Craddock, C
    Szydlo, RM
    Ward, K
    Yong, A
    Kanfer, E
    Apperley, J
    Goldman, JM
    BONE MARROW TRANSPLANTATION, 1998, 21 : S33 - S33
  • [2] Impact of donor leucocyte infusions on outcome after T cell depleted volunteer unrelated donor (VUD) bone marrow transplantation in patients with CML.
    Craddock, C
    Dazzi, F
    Szydlo, R
    Cwynarski, K
    Olavarria, E
    Brookes, P
    Kanfer, E
    Apperley, J
    Goldman, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 32 - 32
  • [3] Outcome after T depleted volunteer unrelated donor (VUD) transplantation in CML: The case for patient specific GVHD prophylaxis.
    Craddock, C
    Szydlo, R
    Ward, K
    Brookes, P
    McKinty, B
    de la Fuente, J
    Olavarria, E
    Yong, A
    Cwynarski, K
    Kanfer, E
    Apperley, J
    Goldman, J
    BLOOD, 1998, 92 (10) : 143A - 143A
  • [4] A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation
    R Stocchi
    R Szydlo
    C Craddock
    E Kanfer
    J F Apperley
    J M Goldman
    K N Ward
    Bone Marrow Transplantation, 1999, 23 : 705 - 709
  • [5] A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation
    Stocchi, R
    Szydlo, R
    Craddock, C
    Kanfer, E
    Apperley, JF
    Goldman, JM
    Ward, KN
    BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 705 - 709
  • [6] A comparison of prophylactic versus preemptive ganciclovir to prevent cytomegalovirus (CMV) disease after volunteer unrelated donor (VUD) bone marrow transplant (BMT) for chronic myeloid leukemia (CML).
    Stocchi, R
    Szydlo, RM
    Craddock, C
    Ward, KN
    Apperley, JF
    Goldman, JM
    BONE MARROW TRANSPLANTATION, 1998, 21 : S141 - S141
  • [7] Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants
    Shaw, B. E.
    Mayor, N. P.
    Szydlo, R. M.
    Bultitude, W. P.
    Anthias, C.
    Kirkland, K.
    Perry, J.
    Clark, A.
    Mackinnon, S.
    Marks, Di
    Pagliuca, A.
    Potter, M. N.
    Russell, N. H.
    Thomson, K.
    Madrigal, J. A.
    Marsh, S. G. E.
    BONE MARROW TRANSPLANTATION, 2017, 52 (05) : 717 - 725
  • [8] Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants
    B E Shaw
    N P Mayor
    R M Szydlo
    W P Bultitude
    C Anthias
    K Kirkland
    J Perry
    A Clark
    S Mackinnon
    D I Marks
    A Pagliuca
    M N Potter
    N H Russell
    K Thomson
    J A Madrigal
    S G E Marsh
    Bone Marrow Transplantation, 2017, 52 : 717 - 725
  • [9] Donor CMV serological status influences the outcome after unrelated donor stem cell transplantation; an EBMT Megafile analysis
    Ljungman, P
    Brand, R
    Brand, R
    Einsele, H
    Frassoni, F
    Niederwieser, D
    Cordonnier, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S52 - S53
  • [10] Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megatile analysis
    Ljungman, P
    Brand, R
    Einsele, H
    Frassoni, F
    Niederwieser, D
    Cordonnier, C
    BLOOD, 2003, 102 (13) : 4255 - 4260
12345